SM
Sabby Management Portfolio holdings
AUM
$13M
1-Year Return
26.95%
This Quarter Return
+0.8%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$1.42M
AUM Growth
+$561K
(+65%)
Cap. Flow
+$1.16M
Cap. Flow
% of AUM
82.05%
Top 10 Holdings %
Top 10 Hldgs %
85.81%
Holding
200
New
32
Increased
31
Reduced
36
Closed
35
Top Buys
| 1 |
Pfizer
PFE
|
$39.1K |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$27.4K |
| 3 |
Merck
MRK
|
$12K |
| 4 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$11.6K |
| 5 |
Gilead Sciences
GILD
|
$10.7K |
Top Sells
| 1 |
Acadia Healthcare
ACHC
|
$16.4K |
| 2 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$9.99K |
| 3 |
Tesla
TSLA
|
$7.93K |
| 4 |
Larimar Therapeutics
LRMR
|
$6.67K |
| 5 |
Ocular Therapeutix
OCUL
|
$4.66K |
Sector Composition
| 1 | Healthcare | 20.45% |
| 2 | Energy | 0.93% |
| 3 | Industrials | 0.31% |
| 4 | Consumer Staples | 0.23% |
| 5 | Technology | 0.2% |
